US 10138255
Piperazine derivatives as HIV protease inhibitors
granted A61KA61K31/554A61K45/06
Quick answer
US patent 10138255 (Piperazine derivatives as HIV protease inhibitors) held by MSD R&D (China) Co. Ltd. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MSD R&D (China) Co. Ltd.
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/554, A61K45/06, A61P, A61P31/18